LOS ANGELES, Aug. 21 /Xinhua-PRNewswire/ -- China Pharma Holdings, Inc.
("China Pharma") (OTC Bulletin Board: CPHI), a leading specialty
bio-pharmaceutical company that develops, manufactures, and markets generic
and brand products in China announced today that its Vice President,
Strategic Planning and Business Development, Donald Xu, and Chief Financial
Officer, Xinhua Wu will present at the upcoming Roth Capital Partners 2006
New York Conference.
The Roth Capital Partners Conference features presentations from over
200 small and micro cap companies with a focus on undiscovered companies as
well as international companies that aren't well known to U.S. investors in
the technology, healthcare, financial services and consumer products
sectors.
Date: Thursday, September 7, 2006
Time: 1:30 PM Eastern Time
Venue: The Westin Times Square Hotel, New York
Live webcast: http://www.rothconference.com /
A replay of the webcast will be available for 60 days at:
http://www.rothconference.com/
Interested parties and institutional investors may register for the
conference by visiting the conference website at
http://www.rothconference.com/ or by calling Roth Capital Partners at (800)
678-9147.
About China Pharma Holdings, Inc.
China Pharma Holdings, Inc. develops, manufactures, and markets generic
and brand bio-pharmaceutical products in China that treat a wide range of
conditions, including infections, hepatitis, cardiovascular and CNS
diseases, and other prevailing diseases. Helpson Bio-pharmaceutical Co.,
Ltd (Helpson), a specialty bio-pharmaceutical company headquartered in
Haikou City, Hainan province in China, is a wholly owned subsidiary of
China Pharma Holdings.
SOURCE China Pharma Holdings, Inc.
 back to top
Related links:
http://www.rothconference.com
CONTACT:
Donald Xu of China Pharma Holdings, Inc.,
+1-858-776-8880, dxu@chinapharmaholdings.com; Investor Relations,
Crocker Coulson, +1-310-477-9800, ext. 103,
crocker.coulson@ccgir.com
|
